Organization
Institut Mérieux SA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Institut Mérieux SA
... director and will continue to fulfill his responsibilities as Vice President of Institut Mérieux. Working alongside Alain Mérieux, he will be in charge specifically of ...
... the U.S. and Europe, that have participated to this transaction together with Institut Mérieux. This private placement allows us to reinforce our cash position and ...
... ) following the live event. About TransgeneTransgene S.A. (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biotechnology company focused on designing and ...
... the IDFF (Infectious Diseases Finance Facility) program.A commitment by its major shareholder, Institut Mérieux, to provide additional funding of approximately (EURO)10 million. Details of the ...
... company Advanced Bioscience Laboratories (ABL), Inc. Transgene (Euronext: TNG), a member of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and ...
... Transgene, ABL, Inc. and ABL Europe are all three members of the Institut Mérieux. The production asset is designed and equipped to manufacture clinical lots ...
... of Ambroise Fayolle, EIB Vice-President responsible for innovation, Alain Mérieux, Chairman of Institut Mérieux, Transgene's leading shareholder, and Philippe Archinard, Transgene's Chairman and CEO. This ...
... of the Company.Transgene has received a commitment by its major shareholder, the Institut Mérieux, to provide additional financing of around 10 million euros, confirming its ...
... the outcome of the disease. About Transgene: Transgene S.A. (Euronext:TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and ...
... Sofimac Partners, already a shareholder, and by IM Europe, a subsidiary of Institut Mérieux and Crédit Agricole Création. This new funding allows ElsaLys Biotech to ...
... outcome of the disease. About Transgene: Transgene S.A. (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering, developing ...
... in support functions. In accordance with the values of its principal shareholder, Institut Mérieux, Transgene is committed to by all means minimizing as much as ...
... for New Therapeutic Approaches), a program dedicated to personalized medicine, coordinated by Institut Mérieux and supported and partially funded by the French public agency, BPI. ...
... code when dialing into the call. About TransgeneTransgene (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering, developing ...
... especially proud to count as partner a company that was spun-off from Institut Mérieux, a French institution internationally recognized for its excellence in research." About ...
... and long term investors in the industrial sector. The renewed commitment of Institut Merieux and the support of GBL underline the quality of the performance ...
... Ireland, an Irish governmental agency (2006-2009), and at Transgene, Member of the Institut Mérieux group (2002-2005). Between 2000 and 2002, he was Business Development Manager ...
... France - June, 5th 2014 - Merieux Developpement, the investment firm of Institut Merieux, announced today the completion of $21M Series B financing of ImaginAb, ...
Want to see the full history on Institut Mérieux SA? Upgrade to RelSci Pro now!
Start My Free Trial